Search Results 981-990 of 18137 for monoclonal antibody
... monoclonal antibody (eg.daratumumab or isatuximab) - Prior non-belantamab mafodotin anti-BCMA agent exposure is allowed; patients with prior treatment with ...
... monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27. View PubMed; Murphy BL, Glasgow AE, Keeney GL, Habermann ...
A Study Of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) In Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin ...
... antibody, myelin oligodendrocyte glycoprotein — also known as MOG, and an increased risk of recurring attacks in these individuals. Mayo Clinic neurologists ...
Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients. Transpl Infect Dis. 2022 Feb; 24 (1):e13759 Epub 2021 Dec 07. View PubMed ...
The purpose of this study is to establish the positive screening rate for 4°C reacting RBC autoantibodies (4°C RBC autoantibody screen) amongst cardiovascular ...
Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...
About this study. The purpose of this study is to develop single chain variable fragment antibodies against HLA A2 and test their efficacy in blocking the ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... Antibody-drug conjugates, such as lorvotuzumab mertansine, are ...
Monoclonal antibody within 4 weeks. Not recovered from toxicity of any prior chemotherapy to grade ≤ 1. History of other active malignancies within 2 years ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.